Provided by Kendall Taylor of the Valley Schools Employee Benefits Trust (VSEBT) in their March 2016 Wellstyles Monthly Newsletter.
Two young people I know, Kyle and Victoria, seemed to have everything. Kyle worked with his family at the local coffee shop and cafe Hob Nob’s. A smart, great-looking guy, buff and witty, who reminded me of my own son. Victoria the smart, sweet, gorgeous young model with all-American girl next door looks.
Then, this year, both found they had serious cancer. I get updates on Kyle from his family and he has suffered dramatic surgery for soft tissue carcinoma. He seemed fine one day, then he ended up having much of his chest and ribs removed with cancer. He is now going through extensive chemo and radiation treatments. His brother shaved his head in support of Kyle, who has lost his hair.
Victoria had a small spot her on leg. It turned out to be melanoma that had already metastasized. She is in and out of the hospital and going through all sorts of suffering. Still, she is reaching out to help others with awareness.
I don’t usually do this, but:
1) if you are in metro-Phoenix, stop by Hob Nobs and buy a Kyle-strong bracelet.
2) Please go to the donation site below to donate to help Victoria and also watch her video. Thanks.
Seeing Doctor Regularly May Cut Your Colon Cancer Risk
The more often seniors with Medicare coverage visit their primary care physician, the less likely they are to either get colorectal cancer or die from the disease if they do, new research suggests. Moreover, the investigation also found that the greater the frequency of visits, the less likely such seniors were to die of any cause at all.
“Specifically in terms of colorectal cancer this is very important to know, because that is one of the cancers that is preventable,” explained study author Dr. Jeanne Ferrante, an associate professor in the department of family medicine and community health at Rutgers-Robert Wood Johnson Medical School in Somerset, N.J. “And we found that people who do visit their primary care physician are more likely to get screened for colorectal cancer,” she noted. “And those people, in turn, are less likely to get colorectal cancer, as well as less likely to die from it.”
The American Cancer Society recommends that men and women who face an average risk for colorectal cancer begin getting some type of routine screening starting at age 50. That can take the form of a colonoscopy once a decade, or a flexible sigmoidoscopy or virtual CT colonoscopy once every five years, and may result in polyp removal. Those at high risk due to a personal or family history of the disease, polyp development and/or inflammatory bowel disease are encouraged to start screening at an earlier age and to repeat the process more frequently.
For the investigation, the authors sifted through U.S. Surveillance, Epidemiology and End Results (SEER) data on nearly 103,000 Medicare patients newly diagnosed with colorectal cancer between 1994 and 2005. Data covering another approximately 27,000 Medicare patients who died of the disease in that timeframe was also included, as was information on more than 62,000 patients who died of any number of causes. Given that Medicare typically kicks in at age 65 (and that colorectal cancer screening is not advised for people over the age of 85), the average age of those in the study hovered around 76.
A review of Medicare claims paperwork was conducted to identify all primary care visits made during the four– to 27-month period leading up to a cancer diagnosis or death due to colorectal cancer or any other cause.
The result: Patients who had seen a doctor between five and 10 times in the allotted timeframe had a 6% lower risk of disease (and a 22% lower risk of colorectal cancer death) than those who had never seen their doctor or had visited just once. All-cause death rates were 21% lower the more often a patient saw their doctor.
That said, Ferrante stressed that in the world of cancer risk many different factors are at play, making it impossible to draw a simple cause-and-effect link between primary care doctor visits and a reduced risk for colorectal cancer diagnosis and mortality. “For example, we found that although we looked at a group of people that had universal care insurance, still more than one quarter had either never visited a primary care doctor or had done so just once in the study period,” she noted. “So it could be that the Medicare patients who do go in to see their primary care physician are so-called ‘healthy users’ to begin with. By that we mean people who are by definition more concerned about their health and make an effort to take better care of themselves in general,” Ferrante explained. “So, while we do want to emphasize the importance of seeing a primary care physician, the act of going might actually reflect other factors that contribute to a lower cancer risk.”
Dr. Robert Schoen, a professor of medicine and epidemiology at the University of Pittsburgh, suggested that the study should be interpreted as “yet another reason to go see your primary care physician. This looks at a basic research question,” he noted. “What is the benefit of going to a primary care physician? Do routine physicals help? Do blood tests help? What really is of value here?”
“And this study,” Schoen said, “clearly points to a big benefit that comes from going to your doctor, by showing this protective association. Now, there are caveats. Yes, we don’t know if the people who go are more health-conscious to begin with, and because this is based on observational data we don’t actually know what happens during these visits. What did the doctors actually recommend in terms of screenings? But even so, it is logical to presume that the more contact with a primary care physician, the more likely colorectal cancer prevention was discussed and acted on.”
Provided by Rebecca McGonigle, Wellstyles Newsletter, November 2013, Valley Schools Employee Benefits Trust (VSEBT).
Published March 08, 2013
News Corp Australian Papers
The good news is red wine can cure cancer. The bad news is you’d need to drink 100 glasses a day.
While David Sinclair doesn’t recommend that, his work has shown red wine can have health benefits after all. And if things according to plan, they’ll be available in a ‘red wine pill.’
The Australian biologist said an international study, published Friday in the journal Science, had settled a controversy over whether resveratrol, a natural compound found in red wine, can fight cancer, Alzheimer’s and type 2 diabetes.
Ten years ago scientists found resveratrol could activate a “sirtuin” protein known to combat age-related diseases. But the claim was disputed because the reaction could only be observed when a fluorescent chemical known as fluorophore was present.
The new study, which also involved American and Portuguese researchers, showed resveratrol could have the desired effect in the absence of the synthetic chemical.
Sinclair, who shares his time between Harvard and the University of NSW, said fluorophore mimicked “greasy” amino acids that exist naturally in the body.
“It’s as we thought – resveratrol really does turn on this anti-aging enzyme,” Sinclair said.
“It’s more elegant and exciting than just mopping up free radicals. It’s activating our body’s genetic defenses against aging and diseases. That’s probably more effective than any anti-oxidant.”
On the downside, red wine only contains low concentrations of the compound. But Sinclair said synthetic drugs that work the same way but with 100 times the potency could be available in five years.
About 4,000 varieties of the drug have been developed since 2005, with the more promising versions tested on mice and three progressing to human trials.
“The studies are small so we can’t claim victory yet, but the drugs appear to be safe in humans so far,” Sinclair said.
He was “open to the possibility” that small doses of resveratrol could be beneficial. “But drinking a glass or two won’t cure any major diseases. It’s not potent enough.”